May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Posterior Capsule Opacification Rate in Akreos Intraocular Lens Implant
Author Affiliations & Notes
  • A.K. Kotagiri
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • M. Khandwala
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • B. Marjanovic
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • N. Peter
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • M. Teimory
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • K. Harrison
    Ophthalmology, Worthing Hospital, Worthing, United Kingdom
  • Footnotes
    Commercial Relationships  A.K. Kotagiri, None; M. Khandwala, None; B. Marjanovic, None; N. Peter, None; M. Teimory, None; K. Harrison, None.
  • Footnotes
    Support  This study was funded by Bausch & Lomb (UK) Ltd., however the authors have no financial interests in the company or product.
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2545. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.K. Kotagiri, M. Khandwala, B. Marjanovic, N. Peter, M. Teimory, K. Harrison; Posterior Capsule Opacification Rate in Akreos Intraocular Lens Implant . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2545.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the rate of posterior capsule opacification (PCO) of the Akreos intraocular lens implant, with a minimum 18 month follow up.

Methods: : A retrospective analysis of one hundred patients who underwent uncomplicated phacoemulsification with Akreos adapt and fit implants during the period from June 2000 – June 2004 was performed. Patients from a single surgeon’s operating list were recruited into the study. Exclusion criteria included patients with posterior subcapsular cataracts, a history of uveitis, diabetic retinopathy, glaucoma and age related macular degeneration. The protocol included the determination of visual acuity, and the scoring of PCO with EPCO 2000 system by digital photography of the posterior capsule. The number of patients undergoing Nd: YAG–capsulotomy was also recorded.

Results: : Mean follow up was 30 months ( SD–10.3). Mean BCVA was 20/32 ( 0.2 log Mar). Mean EPCO score at 6 mm was 0.36 ( SD–0.35) and at 3 mm was 0.16 ( SD 0.29). YAG capsulotomy rate was recorded as 8.8%.

Conclusions: : All patients showed a stable visual acuity with low rates of PCO at 2.5 years.

Keywords: cataract • intraocular lens • posterior capsular opacification (PCO) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×